Use of Phosphodiesterase-5 Inhibitors and the Risk of Melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use of Phosphodiesterase-5 Inhibitors and the Risk of Melanoma

Published:2022 Issue: Volume: Page:
ISSN:1556-5068
Container-title:SSRN Electronic Journal
language:en
Short-container-title:SSRN Journal

Author:

Wayne George,Atri Elias,Demus Tim,Jivanji Dhaval,Herzog Bryan,Wong Vivian,Garcia Maurilio,Cedeno Juan,Nagoda Elizabeth,Polackwich Alan

Publisher

Elsevier BV

Subject

General Earth and Planetary Sciences,General Environmental Science

Reference23 articles.

1. Phosphodiesterase-5 (PDE 5 ) Inhibitors in the Management of Erectile Dysfunction;S A Huang;Pharmacy and Therapeutics,2013

2. Prevalence and risk factors for erectile dysfunction in the U.S;E Selvin;Am J Med,2007

3. The Global Online Sexuality Survey (GOSS): The United States of America in 2011 Chapter II: Phosphodiesterase Inhibitors Utilization among English Speakers;O Shaeer;The Journal of Sexual Medicine,2013

4. PDE5 inhibitors beyond erectile dysfunction;P Sandner;International Journal of Impotence Research,2007

5. Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy;G Brock;The Journal of urology,2003

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse reactions of PDE5 inhibitors: An analysis of the World Health Organization pharmacovigilance database;Andrology;2023-03-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP